TechnoPulm Overview
Technopulm is developing an advance handheld diagnostics device that uses a remote telemedicine platform to perform a comprehensive examination of the patient thereby eliminating the need to send the patient to hospital for tests. The company has developed the TechnoPulm system (STS), a patented revolutionary spirometry and plethysmography handheld device for complete Pulmonary Function Testing (PFT) in both clinical and home settings, and accurate Lung Volume Measurements (LVM) with all spirometry parameters can be taken in only 20 seconds of one exhaled breath.
Cumulative Funding Raised Over Time ($)
$500KMay 2024
$2.0MOct 2024
Latest News
growth-positive
TechnoPulm raises $2 million to develop a handheld device capable of performing full lung function tests | CTech
TechnoPulm is revolutionizing lung function testing with its innovative handheld device, designed to replace large, expensive machines. This portable tool allows for quick, comprehensive diagnostics in a physicians office, addressing the significant delay in diagnosing chronic respiratory diseases like COPD and asthma. With regulatory approvals in place, TechnoPulm plans to launch its product in Israel and the U.S. by early 2025. The company recently secured a $500,000 seed investment to support its market entry, focusing on establishing distribution and support infrastructure. The devices introduction is expected to shift the diagnostic landscape, enabling rapid, accessible testing and monitoring, particularly benefiting patients in remote areas.
Investment
growth-positive
TechnoPulm: Diagnosing and Monitoring Lung Disease in the Community
TechnoPulm, a company founded in 2016, has developed a handheld device that can diagnose a range of lung diseases. The device, which is essentially a mobile lung-function laboratory, connects to a doctors computer or mobile phone via Bluetooth and can be used in any location. It has been trialed on 161 subjects at the Kaplan Medical Center and has shown promising results. The device is patented in Europe and the US, with additional patents still being filed. TechnoPulm is currently awaiting regulatory approval from Israels Health Ministry and the US Food & Drug Administration.
CustomersPartnersManagement Changes
| Sector | Health Tech & Life Sciences |
Funding
| Total funding | $2M |
| Last funding | $1.5M |
| Stage | Seed |
| Rounds | 2 |
| Investors | 1 |
Team Members
2
Employees: 1-10
Web & Social Links
| Website | t-pulm.com/ |
Locations
Rehovot, Israel
Photos & Videos
1 item(s)
TechnoPulm Business
Business models
B2C
Product stage
R&D
Employees
1-10
Sector
Health Tech & Life SciencesDigital HealthcareDigital TherapeuticsClinical WorkflowDigital Medical DiagnosticsMedical DevicesDiagnostics DevicesTarget Customer
Healthcare & Life SciencesHealthcarePatientsProvidersMedical Devices IndustryMedical ProductsCore Technology
—Tags (3)
pulmonarydiagnosticschronic-diseaseTechnoPulm Financials
$2M
Total funding
Undisclosed
Capital raised
$1.5M
Last funding
Seed
Funding stage
2
Total rounds
1
Investors
Cumulative Funding Raised Over Time ($)
$500KMay 2024
$2.0MOct 2024
Private Equity Funding
Seed
Oct 2024
$1.5M
Undisclosed Round
May 2024
$500K
Israel Innovation Authority
TechnoPulm Lifecycle
Cumulative Funding Raised Over Time
$500KMay 2024
$2.0MOct 2024
All Events
Seed
Oct 2024
$1.5M
Undisclosed Round
May 2024
$500K
Israel Innovation Authority
TechnoPulm News
2 articles
growth-positive
TechnoPulm raises $2 million to develop a handheld device capable of performing full lung function tests | CTech
TechnoPulm is revolutionizing lung function testing with its innovative handheld device, designed to replace large, expensive machines. This portable tool allows for quick, comprehensive diagnostics in a physicians office, addressing the significant delay in diagnosing chronic respiratory diseases like COPD and asthma. With regulatory approvals in place, TechnoPulm plans to launch its product in Israel and the U.S. by early 2025. The company recently secured a $500,000 seed investment to support its market entry, focusing on establishing distribution and support infrastructure. The devices introduction is expected to shift the diagnostic landscape, enabling rapid, accessible testing and monitoring, particularly benefiting patients in remote areas.
Investment
growth-positive
TechnoPulm: Diagnosing and Monitoring Lung Disease in the Community
TechnoPulm, a company founded in 2016, has developed a handheld device that can diagnose a range of lung diseases. The device, which is essentially a mobile lung-function laboratory, connects to a doctors computer or mobile phone via Bluetooth and can be used in any location. It has been trialed on 161 subjects at the Kaplan Medical Center and has shown promising results. The device is patented in Europe and the US, with additional patents still being filed. TechnoPulm is currently awaiting regulatory approval from Israels Health Ministry and the US Food & Drug Administration.
CustomersPartnersManagement Changes
TechnoPulm Team
Igor Krivits
Co-founder & CTO
Founder
Employee Info
| Employees (range) | 1-10 |
| Exact count | 3 |
| Team members | 2 |
Similar Companies
Similar companies data is computed dynamically and not stored in the entity profile. This section requires implementing a similarity query (e.g. by classification overlap, sector, district).
This entity has 13 classification IDs that could be used for matching.
TechnoPulm Internal
Recent Updates
No update log entries.
Note: Free-text notes visible in the original Finder "Internal" tab are not present in the imported profile data. Only the update audit log is available.
Admin Info
| Confidence | 81/100 |
| Missing | sector, markets, not claimed |
| BI Verification | Matan Eblagon |
| Registrar ID | 515486750 |
| Crunchbase | technopulm |
| Creator | Matan Eblagon |
| Creator email | matane@sncentral.org |
| Last updater | Matan Eblagon |
| Updater email | matane@sncentral.org |
| Last update | 2024-10-11T00:00:00.000Z |
| Created | 2024-04-30T00:00:00.000Z |